Steven Cohen's CME Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 15.0K shares of CME Group Inc. (CME) worth $4.05 M, representing 0.01% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Steven Cohen has maintained a long-term strategic position in CME, representing a significant commitment to this investment thesis. Largest addition occurred in Q1 2019, adding 372.5K shares. Largest reduction occurred in Q2 2019, reducing 347.7K shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's CME Group (CME) Holding Value Over Time
Track share changes against reported price movement
Quarterly CME Group (CME) Trades by Steven Cohen
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +30,033 | Add 0.00% | 30,032 | $70.96 |
| Q4 2015 | +15,000 | Add 49.95% | 45,032 | $90.60 |
| Q2 2016 | +15,000 | Add 33.31% | 60,032 | $97.40 |
| Q4 2016 | +231,900 | Add 386.29% | 291,932 | $115.35 |
| Q1 2017 | -231,900 | Reduce 79.44% | 60,032 | $118.80 |
| Q1 2018 | +239,726 | Add 399.33% | 299,758 | $161.74 |
| Q2 2018 | -231,626 | Reduce 77.27% | 68,132 | $163.92 |
| Q3 2018 | -8,100 | Reduce 11.89% | 60,032 | $170.21 |
| Q1 2019 | +372,501 | Add 620.50% | 432,533 | $164.58 |
| Q2 2019 | -347,658 | Reduce 80.38% | 84,875 | $194.11 |
| Q3 2019 | -24,843 | Reduce 29.27% | 60,032 | $211.34 |
| Q3 2021 | +63,600 | Add 105.94% | 123,632 | $193.38 |
| Q4 2021 | -63,600 | Reduce 51.44% | 60,032 | $228.46 |
| Q1 2022 | +6,211 | Add 10.35% | 66,243 | $237.87 |
| Q2 2022 | +51,648 | Add 77.97% | 117,891 | $204.70 |
| Q3 2022 | -35,512 | Reduce 30.12% | 82,379 | $177.13 |
| Q4 2022 | +2,319 | Add 2.82% | 84,698 | $168.16 |
| Q1 2023 | +122,311 | Add 144.41% | 207,009 | $191.52 |
| Q2 2023 | -45,207 | Reduce 21.84% | 161,802 | $185.29 |
| Q3 2023 | -85,600 | Reduce 52.90% | 76,202 | $200.22 |
| Q4 2023 | -1,170 | Reduce 1.54% | 75,032 | $210.60 |
| Q2 2024 | +140,503 | Add 187.26% | 215,535 | $196.60 |
| Q3 2024 | -117,360 | Reduce 54.45% | 98,175 | $220.65 |
| Q4 2024 | -83,175 | Reduce 84.72% | 15,000 | $232.23 |
| Q1 2025 | +175,311 | Add 1168.74% | 190,311 | $265.29 |
| Q2 2025 | -110,755 | Reduce 58.20% | 79,556 | $275.62 |
| Q3 2025 | -64,556 | Reduce 81.15% | 15,000 | $270.19 |
Steven Cohen's CME Group Investment FAQs
Steven Cohen first purchased CME Group Inc. (CME) in Q2 2014, acquiring 30,032 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held CME Group Inc. (CME) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's largest addition to CME Group Inc. (CME) was in Q1 2019, adding 432,533 shares worth $71.19 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 15,000 shares of CME Group Inc. (CME), valued at approximately $4.05 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CME Group Inc. (CME) represents approximately 0.01% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen's peak holding in CME Group Inc. (CME) was 432,533 shares, as reported at the end of Q1 2019. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.